亚洲AV成人片无码,伊人久久大香色综合久久,国产又粗又长又猛又爽的视频,嫩小槡BBBB槡BBBB槡免费,欧美性xxxXXXX

來源：士卓曼官網

上海，2025年9月29日：士卓曼集團宣布，集團已向南京市中級人民法院提起兩項訴訟，指控北京卡爾斯醫療器械有限公司及卡爾斯（南京）醫療器械有限公司專利侵權及實施不正當競爭行為。兩案均已獲南京市中級人民法院正式受理。

士卓曼集團種植事業部負責人安德里亞·烏茨（Andreas Utz）表示：“20多年來，士卓曼始終深耕中國醫療健康生態系統。通過近30年持續投資研發、本土合作及人才培養，我們在推動高質量創新、專業培訓及患者護理等方面做出了巨大貢獻。保護我們的研發成果能確保持續不斷地為全球臨床醫生和患者提供尖端的解決方案——對于BLX這類創新產品而言，這一點尤為重要。”

展望未來，士卓曼將繼續全力投入中國市場，擴大本土研發、加強教育項目、深化與本土醫療健康合作伙伴的關系。

作為包括士卓曼BLX、TLX在內的多項種植體系統的發明人，奧菲爾·弗羅莫維奇教授（ Prof. Dr. Ophir Fromovich ） 表示： “ 保護知識產權對支持創新驅動型市場至關重要。專利維權有助于維護投資者信心、市場穩定性和全球合作吸引力。身為種植體系統的發明人，我深知保護創新成果的重要性——唯有如此，才能持續提升患者護理水平，推動該領域研發不斷進步。”

作為全球牙科解決方案的領導者，士卓曼將因地制宜地向國內引入國際標準。集團也將致力于通過推動真正創新、培育專業人才、維護市場誠信，為中國牙科事業的未來發展貢獻力量。

士卓曼集團期待繼續與中國合作伙伴攜手，共同構建更加健康、更具創新、更以患者為中心的醫療體系。

###

About Straumann Group

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs close to 12 000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland

Phone: +41 (0)61 965 11 11

Homepage: www.straumann-group.com

Contacts:

Corporate Communication

E-mail: corporate.communication@straumann.com

Investor Relations

E-mail: investor.relations@straumann.com

Disclaimer

This press release contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements are made. Forward-looking statements are neither historical facts nor assurances of future performance. They may, but need not, be identified by words such as: "anticipate," "intend," "plan," "goal," "believe," "project," "estimate," "expect," "future," "likely," "may," "should," "will" and similar references to future periods or events. Such forward-looking statements reflect the views, beliefs, assumptions and expectations of Straumann Group or its management at the time the statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may be outside of Straumann Group’s control. Such known and unknown risks, uncertainties and other factors underlying forward-looking statements may cause the actual results, performance or achievements of the Group to differ materially from those expressed or implied in this document. Accordingly, you should not rely on any forward-looking statements contained in this press release. Important factors that could cause the Group’s expectations regarding future results, performance or achievements to differ materially from those expressed in a forward-looking statement include, but are not confined to, future global economic conditions, pandemics, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Straumann Group's control. Should one or more of these risks, uncertainties or other factors materialize or should underlying views, beliefs, assumptions or expectations prove incorrect, actual outcomes may vary materially from those forecasted or expected. Straumann Group is providing the information in this release as of the date it is issued and does not undertake any obligation to update any statements as a result of new information, future events or otherwise.??This release constitutes neither an offer to sell nor a solicitation to buy any securities.